Abt Dominik, Lütolf Sandro, Giudici Nicola
Klinik für Urologie, Spitalzentrum Biel/Centre hospitalier Bienne, Schweiz.
Ther Umsch. 2023 Apr;80(3):123-126. doi: 10.1024/0040-5930/a001424.
Prostatic Artery Embolization (PAE) - Endo-vascular Treatment of Lower Urinary Tract Symptoms Presumed Secondary to Benign Prostatic Obstruction Based on the available evidence on efficacy and safety in the short to midterm, Prostatic Artery Embolization (PAE) is now endorsed by international evidence-based guidelines as a treatment of lower urinary tract symptoms presumed secondary to benign prostatic obstruction (LUTS/BPO) for selected patients. As PAE has a unique treatment approach (i.e., endovascular instead of transurethral), its profile and ideal application differ clearly from other treatments of LUTS/BPO, which must be considered for patient selection. Performance in local anesthesia with ongoing anticoagulation and no upper prostate size limitation represent advantages of the technique. Limited availability, an inferior relief of obstruction associated with higher retreatment rates and inferior outcomes in small prostates represent disadvantages. This should be considered for patient selection and counselling.
前列腺动脉栓塞术（PAE）——对假定由良性前列腺梗阻继发的下尿路症状的血管内治疗 根据短期至中期疗效和安全性的现有证据，前列腺动脉栓塞术（PAE）现已得到国际循证指南认可，作为对选定患者的假定由良性前列腺梗阻继发的下尿路症状（LUTS/BPO）的一种治疗方法。由于PAE具有独特的治疗方式（即血管内而非经尿道），其特点和理想应用明显不同于LUTS/BPO的其他治疗方法，在患者选择时必须予以考虑。在局部麻醉下进行且持续抗凝以及对前列腺大小无上限限制是该技术的优势。可及性有限、与较高的再次治疗率相关的梗阻缓解较差以及在小前列腺中疗效较差是其劣势。在患者选择和咨询时应考虑到这一点。
